Indivior PLC Ordinary Shares
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly … Read more
Indivior PLC Ordinary Shares (INDV) - Total Assets
Latest total assets as of September 2025: $1.42 Billion USD
Based on the latest financial reports, Indivior PLC Ordinary Shares (INDV) holds total assets worth $1.42 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Indivior PLC Ordinary Shares - Total Assets Trend (2016–2024)
This chart illustrates how Indivior PLC Ordinary Shares’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Indivior PLC Ordinary Shares - Asset Composition Analysis
Current Asset Composition (December 2024)
Indivior PLC Ordinary Shares's total assets of $1.42 Billion consist of 63.6% current assets and 36.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 24.2% |
| Accounts Receivable | $254.00 Million | 19.3% |
| Inventory | $178.00 Million | 13.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $5.00 Million | 0.4% |
| Goodwill | $2.00 Million | 0.2% |
Asset Composition Trend (2016–2024)
This chart illustrates how Indivior PLC Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Indivior PLC Ordinary Shares's current assets represent 63.6% of total assets in 2024, a decrease from 81.9% in 2016.
- Cash Position: Cash and equivalents constituted 24.2% of total assets in 2024, down from 57.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 19.3% of total assets.
Indivior PLC Ordinary Shares Competitors by Total Assets
Key competitors of Indivior PLC Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Indivior PLC Ordinary Shares - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Indivior PLC Ordinary Shares generates 0.90x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Indivior PLC Ordinary Shares generates $ 0.15 in net profit.
Indivior PLC Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.96 | 0.83 | 1.80 |
| Quick Ratio | 0.79 | 0.65 | 1.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-43.00 Million | $ -163.00 Million | $ 638.75 Million |
Indivior PLC Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between Indivior PLC Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 145.25 |
| Latest Market Cap to Assets Ratio | 2.19 |
| Asset Growth Rate (YoY) | -32.5% |
| Total Assets | $1.32 Billion |
| Market Capitalization | $2.89 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Indivior PLC Ordinary Shares's assets at a significant premium ( 2.19x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Indivior PLC Ordinary Shares's assets decreased by 32.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Indivior PLC Ordinary Shares (2016–2024)
The table below shows the annual total assets of Indivior PLC Ordinary Shares from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $1.32 Billion | -32.50% |
| 2023-12-31 | $1.95 Billion | +9.86% |
| 2022-12-31 | $1.78 Billion | -2.73% |
| 2021-12-31 | $1.83 Billion | +19.43% |
| 2020-12-31 | $1.53 Billion | -7.32% |
| 2019-12-31 | $1.65 Billion | +6.79% |
| 2018-12-31 | $1.55 Billion | +7.13% |
| 2017-12-31 | $1.44 Billion | +19.44% |
| 2016-12-31 | $1.21 Billion | -- |